Yanyang Tu

Science Research Center, Huizhou Central People's Hospital

Affiliated withHuizhou Central People's Hospital

Research Area

Biography

Yanyang Tu has not added Biography.
If you are Yanyang Tu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Knockdown of CLC-3 may improve cognitive impairment caused by diabetic encephalopathy. Diabetes research and clinical practice\| PubMed ID: 35792204	2022
The application of Aptamer in biomarker discovery. Biomarker research\| PubMed ID: 37468977	2023
Progress in building clinically relevant patient-derived tumor xenograft models for cancer research. Animal models and experimental medicine\| PubMed ID: 37679891	2023
FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma. Open medicine (Warsaw, Poland)\| PubMed ID: 38152333	2023
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis. Frontiers in immunology\| PubMed ID: 38799446	2024
GARNL3 identified as a crucial target for overcoming temozolomide resistance in EGFRvIII-positive glioblastoma. American journal of translational research\| PubMed ID: 38883343	2024
Nrf2 in human cancers: biological significance and therapeutic potential. American journal of cancer research\| PubMed ID: 39267682	2024
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy. Journal of translational medicine\| PubMed ID: 39350207	2024
MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies. Discover oncology\| PubMed ID: 39549162	2024
Evaluating KLHDC8A as a biomarker for glioma: impact on survival and proliferation through the Wnt/β-catenin pathway. Discover oncology\| PubMed ID: 39614999	2024
ELK4 induced upregulation of HOMER3 promotes the proliferation and metastasis in glioma via Wnt/β-catenin/EMT signaling pathway. Biology direct\| PubMed ID: 40205485	2025
Adoptive immune cell therapy for colorectal cancer. Frontiers in immunology\| PubMed ID: 40236691	2025
Inorganic and hybrid nanomaterials for NIR-II fluorescence imaging-guided therapy of Glioblastoma and perspectives. Theranostics\| PubMed ID: 40365286	2025
Overcoming barriers in glioblastoma: The potential of CAR T cell immunotherapy. Theranostics\| PubMed ID: 40585996	2025
In vivo CRISPR screening identifies POU3F3 as a novel regulator of ferroptosis resistance in hepatocellular carcinoma via retinoic acid signaling. Cell communication and signaling : CCS\| PubMed ID: 40634958	2025
Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistance. Pathology, research and practice\| PubMed ID: 40651122	2025
Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation. Frontiers in immunology\| PubMed ID: 41098741	2025
High-resolution protein modeling through Cryo-EM and AI: current trends and future perspectives - a review. Frontiers in molecular biosciences\| PubMed ID: 41209584	2025
A fibroblast-specific gene signature as a therapeutic target for glioblastoma developed based on the characteristics of tumor microenvironment. European journal of medical research\| PubMed ID: 41310846	2025
Fucoidan in cancer therapy: from biomedical application to medicinal chemistry approach. Journal of materials science. Materials in medicine\| PubMed ID: 41343091	2025
RBM7 suppresses mitochondrial dysfunction and ferroptosis by destabilizing FBXL16 mRNA to enhance Temozolomide resistance in glioblastoma. Molecular genetics and genomics : MGG\| PubMed ID: 41381783	2025
Rewiring immune evasion in liver metastases: WNT11 as a central node - a mini review. Frontiers in oncology\| PubMed ID: 41426343	2025
Optimized federated learning framework with RegNetZ and Swin-Transformer for multimodal pancreatic cancer detection1. Scientific reports\| PubMed ID: 41444372	2025
REST-driven upregulation of SFXN3 promotes AML progression via Wnt/β-catenin activation and confers decitabine resistance. Translational oncology\| PubMed ID: 41720050	2026
The emerging landscape of lncRNAs in gastric cancer immunity: From immune escape to ferroptosis and metabolic reprogramming. Biochemical and biophysical research communications\| PubMed ID: 41747446	2026
STAT3-driven EMT in cancer metastasis and chemoresistance: A review. International journal of biological macromolecules\| PubMed ID: 41825674	2026
SP1-IKBIP axis promotes the proliferation and invasion of glioma with Wnt/β-catenin associated epithelial-mesenchymal transition. American journal of cancer research\| PubMed ID: 42004064	2026